Metropolitan Life Insurance Company (MetLife)’s Select Medical SEM Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio SEM Stock Details SEM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-10,557	Closed	-$171K	–	1751
2024 Q1	$171K	Sell	10,557 -562	-5%	-$8.23K	0.01%	778
2023 Q4	$141K	Hold	11,119	–	–	0.01%	911
2023 Q3	$151K	Buy	11,119 +397	+4%	+$6.13K	0.01%	808
2023 Q2	$184K	Hold	10,722	–	–	0.01%	711
2023 Q1	$149K	Sell	10,722 -1,221	-10%	-$18K	0.01%	788
2022 Q4	$160K	Buy	11,943 +326	+3%	+$4.21K	0.01%	818
2022 Q3	$138K	Sell	11,617 -985	-8%	-$14K	0.01%	835
2022 Q2	$160K	Hold	12,602	–	–	0.01%	809
2022 Q1	$163K	Sell	12,602 -41,615	-77%	-$550K	0.01%	927
2021 Q4	$859K	Hold	54,217	–	–	0.01%	1073
2021 Q3	$1.06M	Sell	54,217 -3,926	-7%	-$77.9K	0.02%	908
2021 Q2	$1.32M	Buy	58,143 +3,599	+7%	+$74.7K	0.02%	796
2021 Q1	$1M	Sell	54,544 -2,359	-4%	-$38.7K	0.02%	930
2020 Q4	$848K	Sell	56,903 -4,094	-7%	-$53.4K	0.01%	998
2020 Q3	$684K	Sell	60,997 -1,181	-2%	-$11.6K	0.01%	985
2020 Q2	$493K	Hold	62,178	–	–	0.01%	1208
2020 Q1	$503K	Sell	62,178 -3,690	-6%	-$43.8K	0.01%	1045
2019 Q4	$828K	Sell	65,868 -2,303	-3%	-$24.8K	0.01%	1009
2019 Q3	$609K	Hold	68,171	–	–	0.01%	1177
2019 Q2	$583K	Hold	68,171	–	–	0.01%	1214
2019 Q1	$518K	Hold	68,171	–	–	0.01%	1273
2018 Q4	$564K	Buy	68,171 +1,784	+3%	+$17.1K	0.01%	1120
2018 Q3	$658K	Hold	66,387	–	–	0.01%	1173
2018 Q2	$649K	Hold	66,387	–	–	0.01%	1144
2018 Q1	$617K	Buy	66,387 +1,538	+2%	+$14.6K	0.01%	1143
2017 Q4	$617K	Sell	64,849 -76,203	-54%	-$728K	0.01%	1144
2017 Q3	$1.46M	Hold	141,052	–	–	0.01%	1057
2017 Q2	$1.17M	Hold	141,052	–	–	0.01%	1155
2017 Q1	$1.01M	Sell	141,052 -1,537	-1%	-$11.1K	0.01%	1227
2016 Q4	$1.02M	Buy	142,589 +2,442	+2%	+$17K	0.01%	1284
2016 Q3	$1.02M	Sell	140,147 -4,382	-3%	-$27.9K	0.01%	1269
2016 Q2	$846K	Buy	144,529 +5,600	+4%	+$37.1K	0.01%	1355
2016 Q1	$884K	Buy	138,929 +2,504	+2%	+$13.4K	0.01%	1235
2015 Q4	$875K	Hold	136,425	–	–	0.01%	1257
2015 Q3	$793K	Hold	136,425	–	–	0.01%	1313
2015 Q2	$1.19M	Buy	136,425 +22,984	+20%	+$193K	0.01%	1174
2015 Q1	$906K	Hold	113,441	–	–	0.01%	1251
2014 Q4	$880K	Hold	113,441	–	–	0.01%	1411
2014 Q3	$735K	Hold	113,441	–	–	0.01%	1469
2014 Q2	$953K	Buy	113,441 +38,431	+51%	+$298K	0.01%	1384
2014 Q1	$503K	Hold	75,010	–	–	﹤0.01%	1802
2013 Q4	$469K	Hold	75,010	–	–	﹤0.01%	1854
2013 Q3	$326K	Hold	75,010	–	–	﹤0.01%	2045
2013 Q2	$331K	Buy	+75,010	New	+$332K	﹤0.01%	1984

Other funds holding SEM

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s SEM Position: Q2 2024 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Select Medical (SEM) in Q2 2024, closing a stake of 10,557 shares — an estimated $171K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in SEM in Q2 2013 and held it in 44 quarters. The position peaked at $1.46M in Q3 2017. 256 funds tracked by Wall St. Rank hold SEM as of Q2 2024.

Metropolitan Life Insurance Company (MetLife) reported no remaining Select Medical position as of Q2 2024 after selling out during the quarter.
Metropolitan Life Insurance Company (MetLife) sold 10,557 Select Medical shares in Q2 2024, an estimated $171K.
Metropolitan Life Insurance Company (MetLife) first reported a position in Select Medical in Q2 2013 and held it in 44 quarters.
Metropolitan Life Insurance Company (MetLife)'s Select Medical position peaked at $1.46M in Q3 2017.
256 funds tracked by Wall St. Rank held Select Medical as of Q2 2024.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.